US Patent:
20170327595, Nov 16, 2017
Inventors:
- Foster City CA, US
Joanne I. Adamkewicz - Belmont CA, US
Victoria Smith - Burlingame CA, US
Susan K. Lyman - South San Francisco CA, US
Jason Chien - Seattle WA, US
Xiaoming Li - Bellevue WA, US
Lixin Shao - Bellevue WA, US
International Classification:
C07K 16/40
G01N 33/573
A61K 39/00
Abstract:
Provided are therapeutic, diagnostic, and prognostic methods for disease, including diseases associated with fibrosis and cancer using agents that bind to, inhibit, and/or detect lysyl oxidase-like 2 (LOXL2), and agents, compositions, kits, assay systems, and devices for use with such methods.